| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/13/2008 | CN100409860C Rough gentian soft capsule for treating hepatic diseases |
| 08/13/2008 | CN100409852C Chinese medicine for enhancing immunologic function |
| 08/13/2008 | CN100409839C Ginseng-monkshood skeleton slow-release preparation wax skeleton tablet for treating qi athenia and yang depletion and preparing method thereof |
| 08/13/2008 | CN100409838C Method for producing medicine Yigan dipping-pills for tonifying liver |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411070 Form of S-omeprazole |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors |
| 08/12/2008 | US7410990 Heterocyclic compounds |
| 08/12/2008 | US7410986 For therapy of inflammatory symptoms; tumors, ischemia and tumor |
| 08/12/2008 | US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis |
| 08/12/2008 | US7410981 low toxicity; 2-[methyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimida zol-1-yl]carbonyl]amino]ethyl acetate; superior antiulcer activity, a gastric acid secretion inhibitory action, a mucosa-protecting action, an antiHelicobacter pylori action |
| 08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
| 08/12/2008 | US7410955 Therapeutic use of agonist ligands specific to G2A receptor |
| 08/12/2008 | US7410945 Treatment of inflammatory bowel disease |
| 08/12/2008 | US7410647 Vaccines |
| 08/12/2008 | US7410642 Assays and therapies for latent viral infection |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | CA2504517C Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
| 08/12/2008 | CA2504514C Adsorbent for oral administration |
| 08/12/2008 | CA2432037C Famotidine injection solution |
| 08/12/2008 | CA2408887C Medical composition kit for treating lesioned abnormal tissue |
| 08/12/2008 | CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/12/2008 | CA2359819C 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 08/12/2008 | CA2350786C Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 08/12/2008 | CA2303370C Dentifrices of enhanced efficacy containing fluoride and casein glycomacropeptide |
| 08/07/2008 | WO2008094476A1 Substituted pyrano [2, 3 - b] pyridine derivatives as cannabinoid -1 receptor modulators |
| 08/07/2008 | WO2008094065A1 METHOD AND A THERAPEUTIC AGENT WHICH IS USED FOR TREATING VIRAL HEPATITIS AND BASED ON Enterococcus Faecium M (VKPM B-3490) AND Enterococcus faecium M-3185 (VKPM B- 3491) STRAINS |
| 08/07/2008 | WO2008093826A1 Adiponectin-increasing agent |
| 08/07/2008 | WO2008093793A1 Agent for relief or prevention of xerostomia |
| 08/07/2008 | WO2008093464A1 Animal having modification in mgat2 gene |
| 08/07/2008 | WO2008093236A1 Tricyclic compounds and their use as glucocorticoid receptor modulators |
| 08/07/2008 | WO2008093227A1 Tricyclic compounds and their use as glucocorticoid receptor modulators |
| 08/07/2008 | WO2008092675A1 Phenol-derivatives for use as feed additive |
| 08/07/2008 | WO2008053219B1 Composition for the treatment of gastrointestinal diseases |
| 08/07/2008 | WO2007140222A3 Pyrrolopyrimidine compounds and their uses |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188519 Novel azacyclic ethynyl derivatives |
| 08/07/2008 | US20080188512 Administering N-(1H-tetrazol-5-yl)-1-phenoxy-4H-quinolizin-4-one-3-carboxamide; concomitant use of serotonin 5-HT3 receptor antagonists |
| 08/07/2008 | US20080188495 e.g. 6-[(1E)-2-(3,4-dimethoxyphenyl)vinyl]-3-ethyl-1,5-dimethyl-1,3-dihydrothiopheno[2,3-d]pyrimidine-2,4-dione; neurodegenerative disorders, antiischemic agent, antidepressant, attention deficit disorder, hepatic fibrosis, cirrhosis of the liver, and drug addiction |
| 08/07/2008 | US20080188485 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 08/07/2008 | US20080188473 Indoles Useful in the Treatment of Inflammation |
| 08/07/2008 | US20080188459 antiinflammatory agents; side effects rduction; less toxicity, irritation, allergic response; rheumatoid arthritis, psoriasis, asthma, Crohn's disease, ulcerative colitis, COPD ; rel-N-[(2R,10,14b)-8-cyano-1,2,3,4,10,14b-hexahydro-10-methyldibenzo[c,f]pyrido[1,2-a]azepin-2-yl]-2,2,2-trifluoroacetamide |
| 08/07/2008 | US20080188443 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4b,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; modulators of the glucocorticoid receptor; asthma, dermatitis, inflammatory bowel disease, Alzheimer's disease, psychotic major depression |
| 08/07/2008 | US20080188439 Xenobiotic substance that is hydroxylated or can be hydroxylated, a glucuronidation donor of uridine diphosphoglucuronic acid; reducing the incidence and degree of liver toxicity caused by chemical compounds susceptible to conjugational inactivation in the liver |
| 08/07/2008 | US20080188434 Providing a DNA sample, detecting the amplification of a nucleic acid sequence in chromosomal region 8p22, amplification indicates that the patient has, or is susceptible of developing cancer; inhibition of FGF-20 activity inhibits the growth of cancer cells |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080187577 Immunogenic compositions comprising progastrin and uses thereof |
| 08/07/2008 | US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation |
| 08/07/2008 | US20080187542 Herpesvirus entry mediator (HVEM) specific immunoglobulin for use in treatment and prevention of transplant rejection, graft-versus-host and transplant autoimmune diseases |
| 08/07/2008 | US20080187541 Helicobacter pylori adhesin binding group antigen |
| 08/07/2008 | CA2676167A1 Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators |
| 08/06/2008 | EP1953164A1 Therapeutic or prophylactic agent for functional bowel disorder |
| 08/06/2008 | EP1953147A1 Heterocyclic compound and medicinal application thereof |
| 08/06/2008 | EP1952821A1 Therapeutic agent for dentine-dental pulp complex regeneration |
| 08/06/2008 | EP1952819A2 Method for preventing gastritis using amylin or amylin agonists |
| 08/06/2008 | EP1952818A1 Inhibitor of osteoclast formation, composition for oral administration and prophylactic or therapeutic agent for bone disease comprising lactoferrin-containing liposome |
| 08/06/2008 | EP1952814A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 08/06/2008 | EP1952701A2 Improving longevity and the condition of elderly cats |
| 08/06/2008 | EP1952700A1 Method of improving absorption of vitamin E by a pet animal |
| 08/06/2008 | EP1951872A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 08/06/2008 | EP1951261A2 Compositions and methods for treating inflammatory disorders |
| 08/06/2008 | EP1951065A1 Methods and compositions for improving gastrointestinal health |
| 08/06/2008 | EP1651621B1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1404641B1 Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 08/06/2008 | EP1363875B1 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 08/06/2008 | EP1328515B1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | EP1257298B1 Cosmid dna constructs and methods of making and using the same |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1157042B1 Production of tetravalent antibodies |
| 08/06/2008 | EP1133284B2 A process for the preparation of crystalline particles |
| 08/06/2008 | CN101237884A Int6 protein involved in hypoxia stress induction and use thereof |
| 08/06/2008 | CN101237878A Intralesional treatment of psoriasis |
| 08/06/2008 | CN101237864A Methods and compositions for soothing oral and nasal tissues |
| 08/06/2008 | CN101237781A Confectionery products for the treatment of dry mouth |
| 08/06/2008 | CN101235039A Chemical total synthesis method for wedelolactone |
| 08/06/2008 | CN101235013A Crystallized 1-(3-fluorophenyl)-5-methyl-2-(1H)pyridine and its preparation method composition and application |
| 08/06/2008 | CN101234200A Composition for improving and treating human body digestive system a plurality of malaise symptoms |
| 08/06/2008 | CN101234195A Compound gargle for preventing and controlling stomatitis and confecting method thereof |
| 08/06/2008 | CN101234193A Stable water solution containing recombination human serum albumin fusion interferon |
| 08/06/2008 | CN101234189A Chinese medicine composition for preventing and treating cardiovascular inflammation (toxin) |
| 08/06/2008 | CN101234187A Proprietary chinese medicine for treating mouth ulcer and preparation thereof |
| 08/06/2008 | CN101234184A Orally-administered Chinese medicine composition for treating radiation proctitis |
| 08/06/2008 | CN101234183A Oral cavity anaerobium bacteriostatic and preparation |
| 08/06/2008 | CN101234180A Production method of powder for eliminating mouth ulcer in 12 hours |
| 08/06/2008 | CN101234170A Sanweishengmai injection and preparation thereof |
| 08/06/2008 | CN101234163A Chinese medicine composition, preparation and application thereof |
| 08/06/2008 | CN101234160A Fat-reducing and liver-protecting Chinese medicine preparation and preparation thereof |
| 08/06/2008 | CN101234159A Pharmaceutical combination with synergistic reaction |
| 08/06/2008 | CN101234155A Chinese medicine and western medicine integrated oral liquid preparation for quickly treating coprostasis |
| 08/06/2008 | CN101234150A Pharmaceutical composition for foaming elimination poison and promoting menstruation and dissipating mass and preparation thereof |
| 08/06/2008 | CN101234144A Dropping pills for treating toothache and preparation thereof |
| 08/06/2008 | CN101234128A Paederus extraction liquid and preparation and application thereof |
| 08/06/2008 | CN101234122A New purpose of polylysine |
| 08/06/2008 | CN101234093A Lozenge containing phenoxymethylpenicillin potassium with medicative for mouth ulcer and preparation thereof |
| 08/06/2008 | CN101234078A Preparation technique of blood streptococcus signal molecule micro-ecological preparations and oral health products thereof |